<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Patients were ineligible if they had palpable breast lesions, were under 19 or over 80Â years of age, were pregnant, had skin disease (scleroderma or systemic lupus erythematosus, for example), had a history of radiotherapy, neoadjuvant therapy, inflammatory breast cancer, or and drug (charcoal, indocyanine green, hyaluronic acid). Among 50 patients who consented to participating in the trial, six were excluded because of withdrawal of consent, cancellation of surgery, or ineligibility.</p>
